Mad Money with Jim Cramer - MAD CAP RECAP - The Official Mad Money Blog
RSS FEED
RECENT POSTS
- Cramer’s One-on-One with Airgas CEO
- Lightning Round: Advance Auto Parts, Michael Kors, Pilgrim's and More
- How Gap Stores Turned Things Around
- Cramer Interviews Owens Corning CEO
- Cramer: Europe Is Playing a ‘Game of Chicken’
- Don’t Trust Buybacks
- Buying the Right Sell-Off Stocks
- Buy Broken Stocks, Not Broken Companies
- The Biggest Market Myth There Is?
- The Key to a Successful Turnaround
MAD MONEY FEATURES
PODCASTSWatch the Lightning Round whenever and wherever you want.
OFFICIAL MAD MONEY WIDGETGrab this all-in-one application and get recaps of the show sent right to your desktop or blog.
CRAMERS SOUNDBOARDAdmit it: You've always wanted to hit the "They
know nothing!" button. Here’s your chance.
CHECK OUT OUR PHOTOSCheck out Cramer on set, back to school, behind the scenes and more.
SHOP FOR MAD MERCHANDISEBuy Cramer books, bobbleheads and other Mad Money merchandise.
RING TONESPick up the phone! It's Cramer! New Mad Money sounds for your cell phone.
TEXT MESSAGE ALERTMad Money's mobile. Get show highlights sent to your phone.
Cramer: Buy Bristol-Myers, Pfizer Stock
Text Size 
Producer
Most investors had long stayed away from pharmaceutical stocks because the major drug companies were losing patent protection on their largest products. Although the “patent expiration apocalypse” continues, many investors are now buying big pharma because they think the worst is over.
Cramer sees a major opportunity here and after recommending Merck [MRK
Loading...
()
] on Monday’s “Mad Money,” he’s getting behind Bristol-Myers [BMY
Loading...
()
] and Pfizer [PFE
Loading...
()
], as well.
Bristol-Myers and Pfizer have been working on a groundbreaking drug called Eliquis, an oral anticoagulant that prevents stroke in patients with atrial fibrillation, which is the most common form of cardiac arrhythmia or irregular heartbeat. It appears to be highly effective and could be a needle mover, too. If approved in March, the drug could generate more than $5 billion in peak sales with the money being divided between the two companies.
Cramer said Eliquis is just one reason to own Bristol-Myers and Pfizer, though. Both stocks sports juicy dividend yields of 4.3 and 4 percent respectively.
Call Cramer: 1-800-743-CNBC
Questions for Cramer?
Questions, comments, suggestions for the Mad Money website?
Data is a real-time snapshot *Data is delayed at least 15 minutes
